Senning procedure
Senning procedure is a surgical technique used in the treatment of congenital heart defects, specifically transposition of the great arteries (TGA). The procedure was first described by the Swedish surgeon Åke Senning in 1959.
Overview[edit]
The Senning procedure is a type of atrial switch operation, which aims to correct the blood flow in patients with TGA. In TGA, the two main arteries leaving the heart, the pulmonary artery and the aorta, are switched (transposed). This results in oxygen-rich blood being circulated back to the lungs, while oxygen-poor blood is pumped to the rest of the body. The Senning procedure redirects the blood flow at the atrial level, allowing oxygen-rich blood to reach the body and oxygen-poor blood to be sent to the lungs.
Procedure[edit]
During the Senning procedure, the surgeon creates a tunnel (or baffle) within the atrium to redirect the blood flow. The baffle is made from the patient's own atrial tissue, which reduces the risk of rejection. The procedure is complex and requires a high level of surgical skill. It is typically performed in the first few weeks of life.
Outcomes[edit]
The Senning procedure has been largely replaced by the arterial switch operation, which is thought to have better long-term outcomes. However, the Senning procedure may still be used in certain cases, such as when the patient has other heart defects that make the arterial switch operation unsuitable. Long-term follow-up is required for all patients who have undergone the Senning procedure, as complications can occur.
See also[edit]
-
Senning procedure
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian